Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome

Stopped early · Not applicable

Conditions studied: Short Bowel Syndrome

In brief

This study will assess the tolerability and palatability of an amino acid based oral rehydration solution (enterade®) compared to current oral rehydration solution among children with short bowel syndrome .

Key facts

Study ID

NCT03105362

Run by

Boston Children's Hospital

People needed

4

Starts

2017-08-16

Expected to finish

2018-04-03

Last updated by the study team

2020-02-24

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female patients with a diagnosis of short bowel syndrome (as defined by surgical therapy for congenital or acquired gastrointestinal disease) between the ages of 1-17
• Patients who are in intestinal continuity or with diverting ileostomy, jejunostomy
• Patients must be on a stable enteral nutrition regimen with oral rehydration fluids that are taken orally.
• Stable GI medication regimen (e.g., loperamide, cholestyramine, small bowel bacterial overgrowth (SBBO) regimen)

You may not qualify if…

• Patients receiving IV antibiotics within the previous 72h.
• Patients with a primary diagnosis of a motility disorder (e.g., chronic intestinal pseudo-obstruction) or epithelial cell disorder (e.g., microvillus inclusion disease)
• Malnourished (as defined by Weight/Height Z-score (WHZ) <-2)

Where it is running

• Boston Children's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.